iCAD (ICAD) announced a strategic development and commercialization agreement with Google Health (GOOG, GOOGL) to integrate its artificial intelligence technology into iCAD’s portfolio of breast imaging AI solutions. Marking the first commercial partnership Google Health has entered into to introduce its breast imaging AI into clinical practice, the companies will work together to enhance iCAD’s market-leading breast cancer AI solutions for mammography and expand access to the technology to millions of women and providers worldwide. iCAD will also leverage Google Cloud’s secure, scalable infrastructure, accelerating the time to market for iCAD’s cloud-hosted offerings. Under the definitive agreement, Google has licensed its AI technology for breast cancer and personalized risk assessment to iCAD. iCAD will apply the licensed technology to further improve its 3D and 2D AI algorithms and will commercialize developed products.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ICAD:
